There will be a new two-agency approach for medical device procurement in public hospitals.
Co-op agrees trial and potential supply deal with ASX mining minnow.
Liquidators disappointed as price falls short.
Hotly-contested auction came down to three bidders.
Report follows data revealed by NBR showing huge variation in certifier performance.
Performance fee doubles to $1.6m.
Majority shareholder expects $930m from sale of the Kiwi telco.
Chapman Tripp’s NZX50 funding report shows bank debt still king.
It did not ‘haul in’ everything but targeted sophisticated investors, Du Val says.
Performance fees also being charged against inappropriate benchmarks.